Provided by Tiger Trade Technology Pte. Ltd.

Agios Pharmaceuticals

34.21
+0.53001.57%
Post-market: 34.210.00000.00%17:46 EDT
Volume:926.78K
Turnover:31.55M
Market Cap:2.03B
PE:-4.88
High:34.34
Open:33.60
Low:33.21
Close:33.68
52wk High:46.00
52wk Low:22.24
Shares:59.47M
Float Shares:50.09M
Volume Ratio:1.11
T/O Rate:1.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.0075
EPS(LYR):-7.1203
ROE:-34.34%
ROA:-22.24%
PB:1.98
PE(LYR):-4.80

Loading ...

Agios Pharmaceuticals Submits Supplemental New Drug Application to FDA for Mitapivat

MT Newswires Live
·
May 12

Agios submits FDA sNDA for accelerated approval of mitapivat in sickle cell disease

Reuters
·
May 12

Agios says mitapivat Phase 3 RISE UP trial boosts hemoglobin in sickle cell disease

Reuters
·
May 12

Agios Pharmaceuticals Inc - Expects Snda Filing Acceptance Notice in Q3 2026

THOMSON REUTERS
·
May 12

Agios Submits Snda to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

THOMSON REUTERS
·
May 12

RBC Capital Sticks to Its Hold Rating for Agios Pharma (AGIO)

TIPRANKS
·
May 01

Agios Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 30

Agios publishes 2025 annual report

Reuters
·
Apr 30

Agios Pharmaceuticals announces annual shareholder meeting webcast details

Reuters
·
Apr 30

Stock Track | Agios Pharmaceuticals Soars 9.68% Intraday on Strong Q1 Revenue Beat and Successful Drug Launch

Stock Track
·
Apr 29

Stock Track | Agios Pharmaceuticals Soars 6.07% in Pre-Market on Strong Q1 Earnings Beat

Stock Track
·
Apr 29

Agios Q1 FY26 net loss widens to $99.1 million; net product revenue rises to $18.8 million

Reuters
·
Apr 29

Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q1 Net Loss $1.69 a Share, vs. FactSet Est of $1.80 Loss

MT Newswires Live
·
Apr 29

Biopharma firm Agios Q1 product revenue more than doubles, beats estimates

Reuters
·
Apr 29

Agios Pharmaceuticals Q1 EPS $(1.69) Beats $(1.79) Estimate, Sales $20.746M Beat $13.646M Estimate

Benzinga Earnings
·
Apr 29

BRIEF-Agios Pharmaceuticals Q1 Product Revenue USD 20.746 Million Vs. IBES Estimate USD 13.6 Million

Reuters
·
Apr 29

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Apr 29

Agios Pharmaceuticals Q1 Net Income USD -99.111 Million

THOMSON REUTERS
·
Apr 29

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 29

Agios Pharmaceuticals announces annual shareholder meeting notice

Reuters
·
Apr 25